https://arxiv.universalpublishings.com/id/eprint/99120 2026-06-19T07:21:00Z info:eu-repo/semantics/descriptiveMetadata https://arxiv.universalpublishings.com/id/eprint/99120/ POSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME Jumayeva M.F., Jumayeva M.F. Ahmedova N.Sh., Ahmedova N.Sh. Hepatorenal syndrome (HRS) is a severe complication that occurs in patients with cirrhosis of the liver (LC), characterized by clinical manifestations of renal failure (RF). Type 2 HRS is observed in patients with severe ascites that are refractory to diuretics. The average survival time of patients with type 2 HRS is 6 months. The laboratory criteria for type 2 HRS are the level of creatinine in the blood serum (above 150 mmol/l), characterized by a high plasma content of renin, aldosterone and antidiuretic hormone. Kidney failure develops slowly . 2025-01-22 Maqola NonPeerReviewed application/pdf en https://arxiv.universalpublishings.com/id/eprint/99120/1/9-10_Jumayeva.pdf Jumayeva M.F., Jumayeva M.F., Ahmedova N.Sh., Ahmedova N.Sh. (2025) POSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME. INTERNATIONAL CONFERENCE OF NATURAL AND SOCIAL-HUMANITARIAN SCIENCES, 2 (1). pp. 9-10. https://universalconference.us/index.php/ICNSHS/article/view/3643 info:eu-repo/semantics/objectFile info:eu-repo/semantics/humanStartPage